Abstract: Novel strains of Lactobacillus plantarum GCWB1001 deposited as accession number KCCM12698P, Pediococcus acidilactici GCWB1085 deposited as accession number KCCM12699P, or Lactobacillus rhamnosus GCWB1156 deposited as accession number KCCM12700P are disclosed. The novel strains have the excellent effect of treating or alleviating respiratory diseases. Additionally, provided are a pharmaceutical composition, a health functional food composition, and probiotics, all of which have the effect of treating or alleviating inflammatory diseases or respiratory diseases, containing any one of the novel strains.
Type:
Application
Filed:
April 23, 2021
Publication date:
June 29, 2023
Applicant:
GREEN CROSS WELLBEING CORPORATION
Inventors:
Minjung JANG, Gyeongeun HONG, Gideok PARK, Jaeyoung KIM, Hyunsu KIM, Yongpil HWANG
Abstract: A novel Lactococcus lactis GCWB1176 strain deposited under Accession No. KCCM12687P and uses thereof are disclosed. The Lactococcus lactis GCWB1176 strain has an excellent immune function enhancing effect. In addition, a food composition, a health functional food composition and probiotics having an excellent immune function enhancing effect, containing the novel strain are disclosed.
Type:
Application
Filed:
April 23, 2021
Publication date:
June 8, 2023
Applicant:
GREEN CROSS WELLBEING CORPORATION
Inventors:
Minjung JANG, Gyeongeun HONG, Gideok PARK, Jaeyoung KIM, Hyunsu KIM, Yongpil HWANG
Abstract: The present invention relates to a composition for preventing and treating cancer-related fatigue, characterized by containing a new processed ginseng powder or a new processed ginseng extract having an increased amount of a ginsenoside constituent, which was previously minute, by preparing a saponin-decomposing enzyme and subsequently using hydrolysis by the prepared saponin-decomposing enzyme and an organic acid. The composition according to the present invention can be very effectively used for preventing and treating cancer-related fatigue, the most destructive and universal side effect, which is caused by cancer itself or occurs in association with the treatment of cancer.
Type:
Grant
Filed:
June 4, 2020
Date of Patent:
October 11, 2022
Assignee:
GREEN CROSS WELLBEING CORPORATION
Inventors:
Young Hyo Yoo, Jeom Yong Kim, Joo Young Kim, Sun Kyu Park
Abstract: A functional food composition contains a Lonicera japonica extract as an active ingredient is disclosed. The functional food composition is useful in alleviating irritable bowel syndrome. The Lonicera japonica extract reduces diarrhea and/or intestinal intonation symptoms, thereby exhibiting an effect of alleviating irritable bowel syndrome. A method of treating or alleviating irritable bowel syndrome includes a step of administering a composition to a subject, wherein the composition contains a Lonicera japonica extract.
Type:
Application
Filed:
August 21, 2020
Publication date:
September 22, 2022
Applicant:
GREEN CROSS WELLBEING CORPORATION
Inventors:
Young Hyo YOO, Hae Jung HAN, Jong Bok YUN, JooYoung KIM, Man Heun KIM
Abstract: A probiotic for inhibiting and preventing the progression of a renal disease and a composition containing the same are disclosed. The probiotic contains a novel Lactobacillus acidophilus BP105 strain, a novel Lactobacillus salivarius BP121 strain. The novel probiotics, the Lactobacillus acidophilus BP105 strain and the Lactobacillus salivarius BP121 strain exhibit excellent indoxyl sulfate removal ability, p-cresol removal ability, and phosphorus absorption ability.
Type:
Grant
Filed:
December 13, 2018
Date of Patent:
June 28, 2022
Assignee:
Green Cross Wellbeing Corporation
Inventors:
Su Ae Kim, Chang Taek Oh, Jong Hun Lee, Su Hwan Lim, Jeom Yong Kim, Sun Kyu Park, Min Jung Jang, Min Ju Lim
Abstract: The present invention pertains to a Lonicera Japonica flower water extract composition for preventing or treating Helicobacter pylori infection, the composition containing secoxyloganin as an active ingredient. The extract contains a specific amount of secoxyloganin, and thus exhibited excellent antibacterial effects when used on Helicobacter pylori bacteria, and exhibited excellent effects in terms of reducing Helicobacter pylori IgG antibody expression in the blood, alleviating histopathological lesions, and reducing cytokine expression when used on Helicobacter pylori-infected mice. Thus, the Lonicera Japonica flower water extract of the present invention can be usefully used as a composition for preventing or treating Helicobacter pylori infection.
Type:
Application
Filed:
November 29, 2019
Publication date:
January 27, 2022
Applicant:
GREEN CROSS WELLBEING CORPORATION
Inventors:
Jeom Yong KIM, Sun Kyu PARK, Min Jung JANG, Jong Hoon LEE, Su Hwan LIM
Abstract: The present invention relates to a composition for promoting myogenesis, containing, as an active ingredient, a processed ginseng extract in which a trace amount of a ginsenoside ingredient is increased. It has been ascertained that the processed ginseng extract promotes the differentiation of myoblasts into muscle and inhibits muscle atrophy caused by myostatin, which is a myogenesis inhibitory factor, and thus it is expected that a composition for preventing or treating muscle disorder-related diseases, having excellent effects, can be developed.
Type:
Application
Filed:
May 24, 2019
Publication date:
July 8, 2021
Applicant:
GREEN CROSS WELLBEING CORPORATION
Inventors:
Sun Kyu PARK, Jeom Yong KIM, Young Hyo YOO, Min Jung JANG, Chang Taek OH, Min Ju LIM, Gwan Su YI, Yi LI, Yoon Hyeok LEE, Jae Cheal YOO
Abstract: A probiotic for inhibiting and preventing the progression of a renal disease and a composition containing the same are disclosed. The probiotic contains a novel Lactobacillus acidophilus BP105 strain, a novel Lactobacillus salivarius BP121 strain. The novel probiotics, the Lactobacillus acidophilus BP105 strain and the Lactobacillus salivarius BP121 strain exhibit excellent indoxyl sulfate removal ability, p-cresol removal ability, and phosphorus absorption ability.
Type:
Application
Filed:
December 13, 2018
Publication date:
June 10, 2021
Applicant:
Green Cross Wellbeing Corporation
Inventors:
Su Ae KIM, Chang Taek OH, Jong Hun LEE, Su Hwan LIM, Jeom Yong KIM, Sun Kyu PARK, Min Jung JANG, Min Ju LIM
Abstract: The present invention provides a cosmetic composition and a pharmaceutical composition comprising secretions of natural killer cells, which are excellent in increasing various factors related to improvement of atopic dermatitis, hair loss, wounds or skin wrinkles, and in enhancing an expression level, and thereby having excellent alleviation effects on the symptoms.
Type:
Application
Filed:
December 13, 2018
Publication date:
December 10, 2020
Applicant:
Green Cross Wellbeing Corporation
Inventors:
Chang Taek OH, Min Ju LIM, Jeom Yong KIM, Sun Kyu PARK, Jong Hun LEE, Min Jung JANG, Su AE KIM, Su Hwan LIM, Beom Joon KIM, Dong HO BAK, Tae Rin KWON, Jung Tae NA
Abstract: The present invention relates to a composition for preventing and treating cancer-related fatigue, characterized by containing a new processed ginseng powder or a new processed ginseng extract having an increased amount of a ginsenoside constituent, which was previously minute, by preparing a saponin-decomposing enzyme and subsequently using hydrolysis by the prepared saponin-decomposing enzyme and an organic acid. The composition according to the present invention can be very effectively used for preventing and treating cancer-related fatigue, the most destructive and universal side effect, which is caused by cancer itself or occurs in association with the treatment of cancer.
Type:
Application
Filed:
June 4, 2020
Publication date:
September 24, 2020
Applicant:
GREEN CROSS WELLBEING CORPORATION
Inventors:
Young Hyo YOO, Jeom Yong KIM, Joo Young KIM, Sun Kyu PARK
Abstract: The present invention relates to a composition for preventing and treating cancer-related fatigue, characterized by containing a new processed ginseng powder or a new processed ginseng extract having an increased amount of a ginsenoside constituent, which was previously minute, by preparing a saponin-decomposing enzyme and subsequently using hydrolysis by the prepared saponin-decomposing enzyme and an organic acid. The composition according to the present invention can be very effectively used for preventing and treating cancer-related fatigue, the most destructive and universal side effect, which is caused by cancer itself or occurs in association with the treatment of cancer.
Type:
Grant
Filed:
August 30, 2013
Date of Patent:
July 14, 2020
Assignee:
GREEN CROSS WELLBEING CORPORATION
Inventors:
Young Hyo Yoo, Jeom Yong Kim, Joo Young Kim, Sun Kyu Park
Abstract: A method for preparing a processed ginseng or a processed ginseng extract having increased contents of ginsenosides Rg3 and Rh2 by (a) inoculating an Aspergillus niger strain into a medium composed of ginseng and wheat bran; (b) culturing the strain of step (a); (c) purifying the cultured material of step (b) by ultrafiltration; (d) separating an enzyme from the purified material of step (c); (e) adding the enzyme of step (d) to ginseng or red ginseng; (f) fermenting the ginseng or red ginseng of step (e); (g) separating the fermented material of step (f) to obtain a supernatant; (h) concentrating the supernatant of step (g); (i) reacting the concentrate of step (h) with organic acid; and (j) neutralizing, filtering, purifying, concentrating and drying the reaction product of step (i).
Type:
Grant
Filed:
May 13, 2011
Date of Patent:
December 6, 2016
Assignee:
GREEN CROSS WELLBEING CORPORATION
Inventors:
Young-Hyo Yoo, Sun-Ok Kim, Jung Hyo Choi, Soo-Hyun Bae, Sun Kyu Park, Jeom Yong Kim
Abstract: The present invention relates to a composition for preventing and treating cancer-related fatigue, characterized by containing a new processed ginseng powder or a new processed ginseng extract having an increased amount of a ginsenoside constituent, which was previously minute, by preparing a saponin-decomposing enzyme and subsequently using hydrolysis by the prepared saponin-decomposing enzyme and an organic acid. The composition according to the present invention can be very effectively used for preventing and treating cancer-related fatigue, the most destructive and universal side effect, which is caused by cancer itself or occurs in association with the treatment of cancer.
Type:
Application
Filed:
August 30, 2013
Publication date:
July 28, 2016
Applicant:
GREEN CROSS WELLBEING CORPORATION
Inventors:
Young Hyo YOO, Jeom Yong KIM, Joo Young KIM, Sun Kyu PARK